StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.63−0.16 (-4.22%)

Close on Nov 16, 2026Market cap $198.49MP/E –Yield –

Intercure ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -10.10M ILS. The highest annual figure on record is 62.33M ILS in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-10.10M ILS–
FY2024Dec 31, 2024-51.84M ILS–
FY2023Dec 31, 2023-28.40M ILS-145.6%
FY2022Dec 31, 202262.33M ILS+75.2%
FY2021Dec 31, 202135.58M ILS–
FY2020Dec 31, 2020-35.15M ILS–
FY2019Dec 31, 2019-2.59M ILS–

More Intercure figures

See a number that looks wrong?